Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(50.0%)
Phase 3
2(33.3%)
Phase 2
1(16.7%)
6Total
N/A(3)
Phase 3(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT05860920Not Yet Recruiting

Clinical Diagnostic Performance Evaluation of a Measles Rapid Test in Senegal

Role: collaborator

NCT04390594Phase 3Terminated

Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal

Role: collaborator

NCT03880006Not ApplicableCompleted

Universal Coverage of Antiretroviral Treatment in Senegal

Role: collaborator

NCT05050825Not ApplicableUnknown

Validation of a CDSA Strategy to Reduce Antibiotic Prescription in Senegal

Role: collaborator

NCT00132561Phase 2Completed

A Trial of Intermittent Treatment in the Prevention of Malaria in Senegalese Children

Role: collaborator

NCT00132548Phase 3Completed

A Trial of Four Drug Regimens for the Prevention of Malaria in Senegalese Children

Role: collaborator

NCT01454752Not ApplicableCompleted

Intermittent Parasite Clearance (IPC) in Schools: Impact on Malaria, Anaemia and Cognition

Role: collaborator

All 7 trials loaded